Plasma Fractionation Market

1
MarketsandMarkets Presents

• Plasma Fractionation Market By 2021

2

• The global plasma fractionation market is
  estimated to grow at a CAGR of 6.7 from 2016 to
  2021 to reach USD 26.07 Billion by 2021. Growing
  aging population, rising incidences of bleeding
  and immune disorders, and growing use of
  immunoglobulin and alpha-1-antitrypsin are
  expected to propel the growth of this market.
  However, the high cost of plasma products,
  adverse reactions associated with use of
  products, and limited reimbursement policies can
  hinder the growth of this market. Moreover, the
  increasing usage of recombinant coagulation
  factors as an alternative to plasma-derived
  coagulation factors is further hampering the
  growth of this market to a certain extent.
• In this report, the global plasma fractionation
  market is segmented on the basis of products,
  applications, end users, and regions. On the
  basis of products, the market is further
  segmented into albumin, immunoglobulin,
  coagulation factor concentrates, protease
  inhibitors, and other plasma products.

3

• http//www.marketsandmarkets.com/Market-Reports/pl
  asma-fractionation-market-93798284.html
• Based on application types, the plasma
  fractionation market is segmented into neurology,
  immunology, hematology, pulmonology,
  hemato-oncology, rheumatology, critical care, and
  other applications. Similarly, on the basis of
  end-users, the market is segmented into hospitals
  and clinics, clinical research laboratories, and
  academic institutes.

4

• Geographically, the global plasma fractionation
  market is segmented into North America, Europe,
  Asia-Pacific, and the Rest of the World. In 2015,
  North America commanded a major share of the
  market. However, Asia-Pacific is expected to
  witness the highest growth rate during the
  forecast period. Growth in the Asia-Pacific
  market can be attributed to the increasing aging
  population, growing use of albumin and
  immunoglobulin, and increasing focus on better
  diagnosis, prophylactic treatments, and medical
  research.
• Some of the prominent players in the global
  plasma fractionation market include CSL Ltd.
  (Australia), Grifols S.A (Spain), Baxalta
  Incorporated (U.S.), Octapharma AG (Switzerland),
  Kedrion S.p.A (Italy), China Biologic Products,
  Inc. (China), Biotest AG (Germany), LFB S.A
  (France), Bio Product Laboratory Ltd. (U.K.), and
  Sanquin (Netherlands).

5
Contact Us

• Mr. RohanMarkets and Markets UNIT no 802, Tower
  no. 7, SEZMagarpatta city, HadapsarPune,
  Maharashtra 411013, India1-888-600-6441Email
  sales_at_marketsandmarkets.com
• MarketsandMarkets Blog
• http//www.linkedin.com/company/marketsandmarkets
• http//twitter.com/marketsmarkets

6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.